VEDOIZUMAB DOES NOT INCREASE PERIOPERATIVE SURGICAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Poylin, Vitaliy Y.
Cataneo, Jose
Pastrana, Jonathan
Feuerstein, Joseph D.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1806
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [1] Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
    Poylin, Vitaliy Y.
    Serrato, Jose Cataneo
    Del Valle, Jonathan Pastrana
    Feuerstein, Joseph D.
    INTESTINAL RESEARCH, 2022, 20 (01) : 72 - 77
  • [2] Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
    Park, Jihye
    INTESTINAL RESEARCH, 2022, 20 (01) : 1 - 2
  • [3] Perioperative Complications in Inflammatory Bowel Disease
    Beddy, David
    Dozois, Eric J.
    Pemberton, John H.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (07) : 1610 - 1619
  • [4] Perioperative Safety of Tofacitinib in Surgical Inflammatory Bowel Disease Patients
    Lightner, Amy L.
    Vaidya, Prashansha
    Holubar, Stefan
    Warusavitarne, Janindra
    Sahnan, Kapil
    Carrano, Francesco
    Spinelli, Antonino
    Zaghiyan, Karen
    Fleshner, Phillip
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S368 - S368
  • [5] Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
    Anas Alsaleh
    Jill K. J. Gaidos
    Le Kang
    John F. Kuemmerle
    Digestive Diseases and Sciences, 2016, 61 : 2602 - 2607
  • [6] Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
    Alsaleh, Anas
    Gaidos, Jill K. J.
    Kang, Le
    Kuemmerle, John F.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (09) : 2602 - 2607
  • [7] Obesity Does Not Impact Perioperative or Postoperative Outcomes in Patients with Inflammatory Bowel Disease
    Guardado, Jesse
    Carchman, Evie
    Danicic, Ashley E.
    Salgado, Javier
    Watson, Andrew R.
    Celebrezze, James P.
    Medich, David S.
    Holder-Murray, Jennifer
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (04) : 725 - 733
  • [8] Obesity Does Not Impact Perioperative or Postoperative Outcomes in Patients with Inflammatory Bowel Disease
    Jesse Guardado
    Evie Carchman
    Ashley E. Danicic
    Javier Salgado
    Andrew R. Watson
    James P. Celebrezze
    David S. Medich
    Jennifer Holder-Murray
    Journal of Gastrointestinal Surgery, 2016, 20 : 725 - 733
  • [9] OBESITY DOES NOT IMPACT PERIOPERATIVE OR POSTOPERATIVE OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Holder-Murray, J.
    Carchman, E.
    Guardado, J.
    Danicic, A.
    Rivers, C.
    Binion, D.
    Javier, S.
    Watson, A.
    Celebrezze, J.
    Medich, D.
    DISEASES OF THE COLON & RECTUM, 2014, 57 (05) : E234 - E235
  • [10] Infliximab does not increase the risk of complications in the perioperative period in patients with Crohn's disease
    Brzezinski, A
    Armstrong, L
    Del Real, GA
    Parsi, M
    Lashner, B
    Achkar, JP
    GASTROENTEROLOGY, 2002, 122 (04) : A617 - A617
12345